Cite
MLA Citation
Michael Collins. “Burosumab: At Long Last, an Effective Treatment for FGF23‐Associated Hypophosphatemia.” Journal of bone and mineral research, vol. 33, 2018, pp. 1381–1382. http://access.bl.uk/ark:/81055/vdc_100068692943.0x000042